Stay updated on Genetically Engineered NY-ESO-1ᶜ²⁵⁹T Clinical Trial
Sign up to get notified when there's something new on the Genetically Engineered NY-ESO-1ᶜ²⁵⁹T Clinical Trial page.

Latest updates to the Genetically Engineered NY-ESO-1ᶜ²⁵⁹T Clinical Trial page
- Check6 days agoChange DetectedThe clinical trial record for a completed Phase 1 study of engineered NY-ESO-1 T cells for synovial sarcoma is displayed, with detailed study information, results measures, locations, and related publications and documents.SummaryDifference69%

- Check13 days agoChange DetectedThe footer now shows site revision v3.8.0 instead of v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check20 days agoChange DetectedA notice announces an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.SummaryDifference1%

- Check27 days agoChange DetectedThe footer’s site revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check34 days agoChange DetectedThe site revision number in the footer changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record content with an access-denied screen. As a result, essential information about the trial, its documents, and locations is no longer accessible from this page.SummaryDifference21%

Stay in the know with updates to Genetically Engineered NY-ESO-1ᶜ²⁵⁹T Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Genetically Engineered NY-ESO-1ᶜ²⁵⁹T Clinical Trial page.